130 related articles for article (PubMed ID: 27790502)
1. Rifampicin-Induced Concomitant Renal Injury and Hepatitis.
Chogtu B; Surendra VU; Magazine R; Acharya PR; Yerrapragada DB
J Clin Diagn Res; 2016 Sep; 10(9):OD18-OD19. PubMed ID: 27790502
[TBL] [Abstract][Full Text] [Related]
2. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
3. Biphasic Effect of Rifampicin on Bilirubin- A Case Report.
Gopi M; Seshadri MS
J Clin Diagn Res; 2016 Apr; 10(4):OD14-5. PubMed ID: 27190870
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure complicating rifampicin therapy.
Prakash J; Kumar NS; Saxena RK; Verma U
J Assoc Physicians India; 2001 Sep; 49():877-80. PubMed ID: 11837753
[TBL] [Abstract][Full Text] [Related]
5. Acute tubulo-interstitial nephritis requiring dialysis associated with intermittent rifampicin use: case report.
Gallieni M; Braidotti P; Cozzolino M; Romagnoli S; Carpani P
Int J Artif Organs; 1999 Jul; 22(7):477-81. PubMed ID: 10493554
[TBL] [Abstract][Full Text] [Related]
6. Acute rifampicin-associated interstitial tubulopathy in a patient with pulmonary tuberculosis: a case report.
Rosati S; Cherubini C; Iacomi F; Giannakakis K; Vincenzi L; Ippolito G; Palmieri F
J Med Case Rep; 2013 Apr; 7():106. PubMed ID: 23594801
[TBL] [Abstract][Full Text] [Related]
7. A Case Series of Acute Kidney Injury During Anti-tuberculosis Treatment.
Sakashita K; Murata K; Takahashi Y; Yamamoto M; Oohashi K; Sato Y; Kitazono M; Wada A; Takamori M
Intern Med; 2019 Feb; 58(4):521-527. PubMed ID: 30333388
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of Cutaneous Adverse Drug Reactions to Anti-tubercular Drugs and Safe Therapy after Re-challenge - A Retrospective Study.
Sharma RK; Verma GK; Tegta GR; Sood S; Rattan R; Gupta M
Indian Dermatol Online J; 2020; 11(2):177-181. PubMed ID: 32477975
[TBL] [Abstract][Full Text] [Related]
9. [Fulminant, rapidly reversible hepatitis and life-threatening anaphylaxis following rifampicin in an HIV-positive female patient with latent adrenal cortex insufficiency].
Canova CR; Kuhn M; Zellweger U; Reinhart WH
Schweiz Med Wochenschr; 1996 Mar; 126(10):392-7. PubMed ID: 8643939
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Wada M
Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
[TBL] [Abstract][Full Text] [Related]
11. Adverse Drug Reaction Profile in Patients on Anti-tubercular Treatment Alone and in Combination with Highly Active Antiretroviral Therapy.
Sadiq S; Khajuria V; Tandon VR; Mahajan A; Singh JB
J Clin Diagn Res; 2015 Oct; 9(10):FC01-4. PubMed ID: 26557538
[TBL] [Abstract][Full Text] [Related]
12. Acute renal failure caused by rifampicin re-exposure with 10-year of interval.
Tsai TL; Lee CH; Chuang FR; Hsu KT
Chang Gung Med J; 2001 Nov; 24(11):729-33. PubMed ID: 11820654
[TBL] [Abstract][Full Text] [Related]
13. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
14. Rifampicin-induced acute renal failure: a series of 60 patients.
Covic A; Goldsmith DJ; Segall L; Stoicescu C; Lungu S; Volovat C; Covic M
Nephrol Dial Transplant; 1998 Apr; 13(4):924-9. PubMed ID: 9568851
[TBL] [Abstract][Full Text] [Related]
15. Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis.
Dawra S; Mandavdhare HS; Singh H; Prasad KK; Dutta U; Sharma V
Clin Exp Hepatol; 2019 Mar; 5(1):60-64. PubMed ID: 30915408
[TBL] [Abstract][Full Text] [Related]
16. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
Girling DJ
Tubercle; 1978 Mar; 59(1):13-32. PubMed ID: 345572
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review.
Chiba S; Tsuchiya K; Sakashita H; Ito E; Inase N
Intern Med; 2013; 52(21):2457-60. PubMed ID: 24190152
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status.
Durand F; Jebrak G; Pessayre D; Fournier M; Bernuau J
Drug Saf; 1996 Dec; 15(6):394-405. PubMed ID: 8968694
[TBL] [Abstract][Full Text] [Related]
19. A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases.
Covic A; Golea O; Segall L; Meadipudi S; Munteanu L; Nicolicioiu M; Tudorache V; Covic M; Goldsmith DJ
J Indian Med Assoc; 2004 Jan; 102(1):20, 22-5. PubMed ID: 15195854
[TBL] [Abstract][Full Text] [Related]
20. [Clinico-pathological features and possible pathogenesis of rifampicin-induced acute renal failure].
Li X; Wang Y; Zhao M; Zhu Y; Liu Y; Wang H
Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):370-3. PubMed ID: 11798598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
